Please enable JavaScript to continue using this application.

Compare $IMVT vs $IOVA | Chartloom

Compare

$IMVT vs $IOVA

Immunovant Inc · Iovance Biotherapeutics Inc

IMVT

Immunovant Inc

IOVA

Iovance Biotherapeutics Inc

Compare $IMVT vs $IOVA

Comparing Immunovant Inc and Iovance Biotherapeutics Inc

IMVTImmunovant Inc

IOVAIovance Biotherapeutics Inc

IMVTImmunovant Inc

Market cap

$6.29B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

17.6%

52W performance

89.5%

FCF yield

-6.6%

IOVAIovance Biotherapeutics Inc

Market cap

$6.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.69x

Rev growth (TTM)

34.5%

YTD performance

480.2%

52W performance

544.1%

FCF yield

-4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMVT

IOVA

Detailed metrics comparison

IMVT

Immunovant Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

IMVT$6.29B

IOVA$6.53B

Enterprise Value

IMVT$5.49B

IOVA$6.42B

Price

IMVT$30.47

IOVA$14.62

P/E Ratio

IMVTN/A

IOVAN/A

P/S Ratio

IMVT0.00x

IOVA20.09x

EV/Sales

IMVT0.00x

IOVA19.75x

EV/EBITDA

IMVT0.00x

IOVA0.00x

P/B Ratio

IMVT9.44x

IOVA8.75x

P/FCF Ratio

IMVTN/A

IOVAN/A

EV/FCF

IMVT-13.25x

IOVA-21.65x

PEG Ratio

IMVTN/A

IOVAN/A

Forward P/E (NTM)

IMVTN/A

IOVAN/A

Forward P/S (NTM)

IMVTN/A

IOVA12.69x

Revenue (TTM)

IMVT$0

IOVA$325M

Revenue Growth (YoY)

IMVTN/A

IOVA34.5%

Forward Rev Growth

IMVT546.2%

IOVA39.2%

Gross Margin (TTM)

IMVT0.0%

IOVA48.4%

Operating Margin (TTM)

IMVT0.0%

IOVA0.0%

EBITDA Margin (TTM)

IMVT0.0%

IOVA-79.8%

Net Margin (TTM)

IMVT0.0%

IOVA-89.1%

FCF Margin (TTM)

IMVTN/A

IOVA-91.2%

Net Income (TTM)

IMVT$-538M

IOVA$-290M

FCF (TTM)

IMVT$-414M

IOVA$-296M

EPS (TTM)

IMVT-$2.62

IOVA-$0.64

ROE (TTM)

IMVT-6959.0%

IOVA-4051.0%

ROA (TTM)

IMVT-6250.0%

IOVA-3165.0%

ROIC (TTM)

IMVT-6959.0%

IOVA-4047.0%

Cash

IMVT$798M

IOVA$111M

Debt

IMVT$0

IOVA$0

Net Cash/Debt

IMVT$798M

IOVA$111M

Current Ratio (TTM)

IMVT7.27x

IOVA4.35x

Quick Ratio (TTM)

IMVT6.82x

IOVA3.74x

Debt/Equity (TTM)

IMVT0.00x

IOVA0.00x

Debt/Assets (TTM)

IMVT0.0%

IOVA0.0%

Interest Coverage (TTM)

IMVTN/A

IOVAN/A

Net Debt/EBITDA (TTM)

IMVT0.00x

IOVA0.00x

Beta

IMVT0.92

IOVA0.76

52W Performance

IMVT89.5%

IOVA544.1%

YTD Performance

IMVT17.6%

IOVA480.2%

% from 52W High

IMVT-32.9%

IOVA-4.4%

% from 52W Low

IMVT89.5%

IOVA730.7%

Asset Turnover (TTM)

IMVT0.00x

IOVA0.36x

FCF Yield (TTM)

IMVT-6.6%

IOVA-4.5%

Earnings Yield (TTM)

IMVT-8.6%

IOVA-4.4%

Dividend Yield (TTM)

IMVTN/A

IOVAN/A

Rule of 40

IMVT0.0

IOVA-56.7

EV/GP/RG

IMVTN/A

IOVA0.68

Ticker research

View IMVT research View IOVA research

Metric	IMVT Immunovant Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$6.29B	$6.53B
Enterprise Value	$5.49B	$6.42B
Price	$30.47	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	20.09x
EV/Sales	0.00x	19.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.44x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.25x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	12.69x
Revenue & Growth
Revenue (TTM)	$0	$325M
Revenue Growth (YoY)	N/A	34.5%
Forward Rev Growth	546.2%	39.2%
Profitability
Gross Margin (TTM)	0.0%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-79.8%
Net Margin (TTM)	0.0%	-89.1%
FCF Margin (TTM)	N/A	-91.2%
Net Income (TTM)	$-538M	$-290M
FCF (TTM)	$-414M	$-296M
EPS (TTM)	-$2.62	-$0.64
ROE (TTM)	-6959.0%	-4051.0%
ROA (TTM)	-6250.0%	-3165.0%
ROIC (TTM)	-6959.0%	-4047.0%
Financial Health
Cash	$798M	$111M
Debt	$0	$0
Net Cash/Debt	$798M	$111M
Current Ratio (TTM)	7.27x	4.35x
Quick Ratio (TTM)	6.82x	3.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.76
52W Performance	89.5%	544.1%
YTD Performance	17.6%	480.2%
% from 52W High	-32.9%	-4.4%
% from 52W Low	89.5%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-6.6%	-4.5%
Earnings Yield (TTM)	-8.6%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-56.7
EV/GP/RG	N/A	0.68
Ticker research	View IMVT research	View IOVA research

Valuation

P/S Ratio

IMVT

0.00x

IOVA

20.09x

EV/FCF

IOVA

-21.65x

IMVT

-13.25x

Growth & revenue

Revenue Growth TTM

IOVA

34.5%

Forward Revenue Growth

IMVT

546.2%

IOVA

39.2%

Profitability & performance

Gross Margin

IOVA

48.4%

IMVT

0.0%

ROE

IOVA

-4051.0%

IMVT

-6959.0%

FCF Yield %

IOVA

-4.5%

IMVT

-6.6%

52-Week Performance

IOVA

544.1%

IMVT

89.5%

Detailed metrics comparison

IMVT

Immunovant Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

IMVT$6.29B

IOVA$6.53B

Enterprise Value

IMVT$5.49B

IOVA$6.42B

Price

IMVT$30.47

IOVA$14.62

P/E Ratio

IMVTN/A

IOVAN/A

P/S Ratio

IMVT0.00x

IOVA20.09x

EV/Sales

IMVT0.00x

IOVA19.75x

EV/EBITDA

IMVT0.00x

IOVA0.00x

P/B Ratio

IMVT9.44x

IOVA8.75x

P/FCF Ratio

IMVTN/A

IOVAN/A

EV/FCF

IMVT-13.25x

IOVA-21.65x

PEG Ratio

IMVTN/A

IOVAN/A

Forward P/E (NTM)

IMVTN/A

IOVAN/A

Forward P/S (NTM)

IMVTN/A

IOVA12.69x

Revenue (TTM)

IMVT$0

IOVA$325M

Revenue Growth (YoY)

IMVTN/A

IOVA34.5%

Forward Rev Growth

IMVT546.2%

IOVA39.2%

Gross Margin (TTM)

IMVT0.0%

IOVA48.4%

Operating Margin (TTM)

IMVT0.0%

IOVA0.0%

EBITDA Margin (TTM)

IMVT0.0%

IOVA-79.8%

Net Margin (TTM)

IMVT0.0%

IOVA-89.1%

FCF Margin (TTM)

IMVTN/A

IOVA-91.2%

Net Income (TTM)

IMVT$-538M

IOVA$-290M

FCF (TTM)

IMVT$-414M

IOVA$-296M

EPS (TTM)

IMVT-$2.62

IOVA-$0.64

ROE (TTM)

IMVT-6959.0%

IOVA-4051.0%

ROA (TTM)

IMVT-6250.0%

IOVA-3165.0%

ROIC (TTM)

IMVT-6959.0%

IOVA-4047.0%

Cash

IMVT$798M

IOVA$111M

Debt

IMVT$0

IOVA$0

Net Cash/Debt

IMVT$798M

IOVA$111M

Current Ratio (TTM)

IMVT7.27x

IOVA4.35x

Quick Ratio (TTM)

IMVT6.82x

IOVA3.74x

Debt/Equity (TTM)

IMVT0.00x

IOVA0.00x

Debt/Assets (TTM)

IMVT0.0%

IOVA0.0%

Interest Coverage (TTM)

IMVTN/A

IOVAN/A

Net Debt/EBITDA (TTM)

IMVT0.00x

IOVA0.00x

Beta

IMVT0.92

IOVA0.76

52W Performance

IMVT89.5%

IOVA544.1%

YTD Performance

IMVT17.6%

IOVA480.2%

% from 52W High

IMVT-32.9%

IOVA-4.4%

% from 52W Low

IMVT89.5%

IOVA730.7%

Asset Turnover (TTM)

IMVT0.00x

IOVA0.36x

FCF Yield (TTM)

IMVT-6.6%

IOVA-4.5%

Earnings Yield (TTM)

IMVT-8.6%

IOVA-4.4%

Dividend Yield (TTM)

IMVTN/A

IOVAN/A

Rule of 40

IMVT0.0

IOVA-56.7

EV/GP/RG

IMVTN/A

IOVA0.68

Ticker research

View IMVT research View IOVA research

Metric	IMVT Immunovant Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$6.29B	$6.53B
Enterprise Value	$5.49B	$6.42B
Price	$30.47	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	20.09x
EV/Sales	0.00x	19.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.44x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.25x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	12.69x
Revenue & Growth
Revenue (TTM)	$0	$325M
Revenue Growth (YoY)	N/A	34.5%
Forward Rev Growth	546.2%	39.2%
Profitability
Gross Margin (TTM)	0.0%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-79.8%
Net Margin (TTM)	0.0%	-89.1%
FCF Margin (TTM)	N/A	-91.2%
Net Income (TTM)	$-538M	$-290M
FCF (TTM)	$-414M	$-296M
EPS (TTM)	-$2.62	-$0.64
ROE (TTM)	-6959.0%	-4051.0%
ROA (TTM)	-6250.0%	-3165.0%
ROIC (TTM)	-6959.0%	-4047.0%
Financial Health
Cash	$798M	$111M
Debt	$0	$0
Net Cash/Debt	$798M	$111M
Current Ratio (TTM)	7.27x	4.35x
Quick Ratio (TTM)	6.82x	3.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.76
52W Performance	89.5%	544.1%
YTD Performance	17.6%	480.2%
% from 52W High	-32.9%	-4.4%
% from 52W Low	89.5%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-6.6%	-4.5%
Earnings Yield (TTM)	-8.6%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-56.7
EV/GP/RG	N/A	0.68
Ticker research	View IMVT research	View IOVA research